Mayo Clinic gets FDA approval for new imaging agent for recurrent prostate cancer
Mayo Clinic has received U.S. Food and Drug Administration approval to produce and administer Choline C 11 Injection, an imaging agent used during a positron emission tomography (PET) scan to help detect sites of recurrent ...
Nov 8, 2012
0
1